Table 5.
Center-wise socio-demographic and clinical characteristics of women who opted for MTP
| Socio-demographic and clinical characteristics | First wave (22/3/2020 to 31/12/2020) | Second wave (21/3/2021 to 30/6/2021) | Third wave (15/12/2021 to 10/02/2022) | Total MTP cases (%) (all three Covid waves) |
|---|---|---|---|---|
| I) JIPMER, Puducherry | ||||
| Age (in years) | ||||
| ≤ 18 | 1 | 1 | 0 | 2 (1.8%) |
| 18–25 | 23 | 11 | 17 | 51(45.9%) |
| 25–30 | 18 | 5 | 13 | 36 (32.4%) |
| ≥ 30 | 7 | 7 | 8 | 22 (19.9%) |
| Total | 49 | 24 | 38 | 111 (100%) |
| Obstetric profile | ||||
| Unmarried | 2 | 1 | 0 | 3 (2.7%) |
| Primigravida | 12 | 7 | 10 | 29 (26.1%) |
| Gravida-2 | 17 | 4 | 8 | 29 (26.1%) |
| Gravida-3 and above | 18 | 12 | 20 | 50 (45.1%) |
| Total | 49 | 24 | 38 | 111 (100%) |
| Gestational age at admission | ||||
| Up to 7 weeks | 11 | 4 | 3 | 18 (16.2%) |
| 7 weeks–12 weeks | 9 | 4 | 9 | 22 (19.8%) |
| 12 weeks–20 weeks | 29 | 16 | 12 | 57 (51.4%) |
| > 20 weeks | 0 | 0 | 14 | 14 (12.6%) |
| Total | 49 | 24 | 38 | 111 (100%) |
| Methods of MTP | ||||
| Medical method of abortion (MMA) | 35 | 14 | 30 | 79 (71.2%) |
| Surgical (MVA/EVA/D&E) * | 14 | 10 | 8 | 32 (28.8%) |
| Total | 49 | 24 | 38 | 111(100%) |
| Complications during/after MTP | ||||
| Incomplete abortion | 11 | 5 | 9 | 25 (22.5%) |
| No complication | 38 | 19 | 29 | 86 (77.5%) |
| Total | 49 | 24 | 38 | 111 (100%) |
| Post-abortion contraception | ||||
| Barrier | 21 | 9 | 12 | 42 (37.8%) |
| IUCD** | 4 | 3 | 6 | 13 (11.7%) |
| Sterilization | – | – | 5 | 5 (4.5%) |
| Hormonal-oral/injection | 4 | 2 | 3 | 9 (8.1%) |
| No contraception | 20 | 10 | 12 | 42 (37.9%) |
| Total | 49 | 24 | 38 | 111 (100%) |
| II) Apollo, Hyderabad | ||||
| Age (in years) | ||||
| ≤ 18 | – | – | – | – |
| 18–25 | 16 | 6 | 3 | 25(13.9%) |
| 25–30 | 29 | 20 | 12 | 61(34.2%) |
| ≥ 30 | 45 | 24 | 24 | 93(51.9%) |
| Total | 90 | 50 | 39 | 179(100%) |
| Obstetric profile | ||||
| Unmarried | 3 | 1 | 1 | 5(2.9%) |
| Primigravida | 28 | 19 | 10 | 57(31.8%) |
| Gravida-2 | 29 | 20 | 18 | 67(37.4%) |
| Gravida-3 and above | 30 | 10 | 10 | 50(27.9%) |
| Total | 90 | 50 | 39 | 179(100%) |
| Gestational age at admission | ||||
| Up to 7 weeks | 60 | 33 | 27 | 120(67%) |
| 7 weeks – 12 weeks | 22 | 8 | 6 | 36(20.1%) |
| 12 weeks – 20 weeks | 8 | 9 | 4 | 21(11.1%) |
| > 20 weeks | – | – | 2 | 2(1.2%) |
| Total | 90 | 50 | 39 | 179(100%) |
| Methods of MTP | ||||
| Medical method of abortion (MMA) | 13 | 37 | 31 | 81(45.3%) |
| Surgical (MVA/EVA/D&E) * | 77 | 13 | 8 | 98(54.7%) |
| Total | 90 | 50 | 39 | 179(100%) |
| Complications after MTP | ||||
| Incomplete abortion | 2 | 3 | 2 | 7(3.9%) |
| Excessive Bleeding P/V | 2 | – | 1 | 3(1.7%) |
| No complication | 86 | 47 | 36 | 169(94.4%) |
| Total | 90 | 50 | 39 | 179(100%) |
| Post-abortion contraception | ||||
| Barrier | 48 | 10 | 7 | 65(36.3%) |
| IUCD** | 5 | 13 | 8 | 26(14.5%) |
| Sterilization | – | 10 | 5 | 15(8.4%) |
| Hormonal-oral/injection | 31 | 15 | 17 | 63(35.2%) |
| No contraception | 6 | 2 | 2 | 10(5.6%) |
| Total | 90 | 50 | 39 | 179(100%) |
| III) NMMC, Ahmedabad | ||||
| Age (in years) | ||||
| ≤ 18 | – | – | – | – |
| 18–25 | 40 | 15 | 40 | 95(57.9%) |
| 25–30 | 8 | 11 | 20 | 39(23.8%) |
| ≥ 30 | 10 | 6 | 14 | 30(18.3%0 |
| Total | 58 | 32 | 74 | 164(100%) |
| Obstetric Profile | ||||
| Unmarried | – | – | – | – |
| Primigravida | 20 | 11 | 25 | 56(34.1%) |
| Gravida-2 | 18 | 18 | 30 | 66(40.3%) |
| Gravida-3 and above | 20 | 3 | 19 | 42(25.6%) |
| Total | 58 | 32 | 74 | 164(100%) |
| Gestational age at admission | ||||
| Up to 7 weeks | 33 | 18 | 34 | 85(51.8%) |
| 7 weeks – 12 weeks | 15 | 12 | 24 | 51(31.1%) |
| 12 weeks – 20 weeks | 10 | 2 | 9 | 21(12.8%) |
| > 20 weeks | – | – | 7 | 7(4.3%) |
| Total | 58 | 32 | 74 | 164(100%) |
| Methods of MTP | ||||
| Medical method of abortion (MMA) | 7 | 7 | 20 | 34(20.7%) |
| Surgical (MVA/EVA/D&E) * | 51 | 25 | 54 | 130(79.3%) |
| Total | 58 | 32 | 74 | 164(100%) |
| Complications after MTP | ||||
| Incomplete abortion | 3 | 3 | 13 | 19(11.6%) |
| Excessive Bleeding P/V | 2 | 2 | 6 | 10(6.1%) |
| Uterine perforation | 1 | – | 1 | 2(1.2%) |
| No complication | 52 | 27 | 54 | 133(81.1%) |
| Total | 58 | 32 | 74 | 164(100%) |
| Post-abortion contraception | ||||
| IUCD** | 22 | 10 | 21 | 53(32.3%) |
| Sterilization | 2 | – | – | 2(1.2%) |
| Hormonal-oral/injection | 27 | 15 | 23 | 65(39.6%) |
| No contraception | 7 | 7 | 30 | 44(26.9%) |
| Total | 58 | 32 | 74 | 164(100%) |
| IV) MAHE, Manipal | ||||
| Age (in years) | ||||
| ≤ 18 | – | – | – | – |
| 18–25 | – | 2 | – | 2 (7.1%) |
| 25–30 | 1 | 2 | 5 | 8 (28.6%) |
| ≥ 30 | 4 | 3 | 11 | 18 (64.3%) |
| Total | 5 | 7 | 16 | 28 (100%) |
| Obstetric Profile | ||||
| Unmarried | – | – | – | – |
| Primigravida | 1 | 1 | 1 | 3 (10.7%) |
| Gravida-2 | 2 | 2 | 7 | 11 (39.3%) |
| Gravida-3 and above | 2 | 4 | 8 | 14 (50%) |
| Total | 5 | 7 | 16 | 28 (100%) |
| Gestational age at admission | ||||
| Up to 7 weeks | 4 | 5 | 12 | 21(75%) |
| 7 weeks–12 weeks | – | 1 | 4 | 5 (17.9%) |
| 12 weeks–20 weeks | 1 | 1 | – | 2 (7.1%) |
| > 20 weeks | – | – | – | – |
| Total | 5 | 7 | 16 | 28(100%) |
| Methods of MTP | ||||
| Medical method of abortion (MMA) | 5 | 7 | 16 | 28(100%) |
| Surgical (MVA/EVA/D&E) * | – | – | – | – |
| Total | 5 | 7 | 16 | 28(100%) |
| Complications after MTP | ||||
| Incomplete abortion | 1 | 1 | 2 | 4(14.3%) |
| No complication | 4 | 6 | 14 | 24(85.7%) |
| Total | 5 | 7 | 16 | 28(100%) |
| Post-abortion contraception | ||||
| Barrier | 5 | 5 | 12 | 22(78.6%) |
| Hormonal-oral/injection | – | 2 | 4 | 6(21.4%) |
| Total | 5 | 7 | 16 | 28(100%) |
*MVA Manual Vacuum Aspiration, *EVA Electric Vacuum aspiration, *D&E Dilatation and Evacuation, **IUCD Intrauterine contraceptive device